A recent retrospective study [57] found that the over-expression of STAT3 was seen in the chemo-naïve ovarian tissue of patients with advanced ovarian cancer (19/25, 76.0%) and in both platinum-sensitive (78.6%) and platinum-resistant (72.7%) groups. Here, STAT3 is linked to ovarian carcinoma.